表紙
市場調查報告書

全球再生醫療市場:2018年∼2022年

Global Regenerative Medicine Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 321466
出版日期 內容資訊 英文 134 Pages
訂單完成後即時交付
價格
Back to Top
全球再生醫療市場:2018年∼2022年 Global Regenerative Medicine Market 2018-2022
出版日期: 2018年04月16日內容資訊: 英文 134 Pages
簡介

關於再生醫療

再生醫療,是加強、修復、置換或再生疾病和障礙,老化的過程造成損傷的器官及組織的醫療。

Technavio的分析師預測,從2018年到2022年之間,全球再生醫療市場將以18.96%的年複合成長率成長。

本報告提供再生醫療的全球市場調查,市場概要,各技術、應用領域、地區的市場趨勢,市場規模的變化與預測,成長促進因素以及課題分析,競爭情形,主要企業的簡介等全面性資訊。

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模的變化與預測

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情形

第7章 全球再生醫療市場:各技術

  • 市場區隔:各技術
  • 市場比較:各技術
  • 細胞、組織治療
  • 基因治療
  • 市場機會:各技術

第8章 全球再生醫療市場:各應用領域

  • 市場區隔:各應用領域
  • 市場比較:各應用領域
  • 肌肉骨骼
  • 皮膚
  • 心血管
  • 其他
  • 市場機會:各應用領域

第9章 客戶形勢

第10章 地區形勢

  • 市場區隔:各地區
  • 市場比較:各地區
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區
  • 市場機會

第11章 決策架構

第12章 成長要素與課題

  • 市場成長要素
  • 市場課題

第13章 市場趨勢

  • 臨床試驗數的增加
  • 新技術的進步
  • 策略性夥伴關係與收購

第14章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭情形

第15章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • ALLERGAN
  • Integra LifeSciences
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • Zimmer Biomet

第16章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR21891

About Regenerative Medicine

Regenerative medicine augments, repairs, replaces or regenerates organs and tissue that have been damaged by disease, injury, or even by the natural aging process.

Technavio's analysts forecast the global regenerative medicine market to grow at a CAGR of 18.96% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Regenerative Medicine Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • ALLERGAN
  • Integra LifeSciences
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • Zimmer Biomet

Market driver

  • Increasing prevalence of chronic diseases
  • For a full, detailed list, view our report

Market challenge

  • Uncertain regulatory approval
  • For a full, detailed list, view our report

Market trend

  • Emerging technological advances
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY TECHNOLOGY

  • Segmentation by technology
  • Comparison by technology
  • Global regenerative medicine market by cell and tissue-based therapy
  • Global regenerative medicine market by gene therapy
  • Market opportunity by technology
  • Segmentation by application

PART 08: MARKET SEGMENTATION BY APPLICATION

  • Global regenerative medicine market by musculoskeletal application
  • Global regenerative medicine market by dermatology application
  • Global regenerative medicine market by cardiovascular application
  • Global regenerative medicine market by other applications

PART 09: CUSTOMER LANDSCAPE

  • Geographical segmentation

PART 10: REGIONAL LANDSCAPE

  • Regional comparison
  • Regenerative medicine market in Americas - Market size and forecast 2017-2022
  • Regenerative medicine market in EMEA - Market size and forecast 2017-2022
  • Regenerative medicine market in APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Increasing number of clinical trials
  • Emerging technological advances
  • Strategic partnerships and acquisitions

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive landscape

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • ALLERGAN
  • Integra LifeSciences
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • Zimmer Biomet

PART 16: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global medical devices market: Market size 2017
  • Exhibit 02: Global medical devices market: Segmentation
  • Exhibit 03: Market characteristics
  • Exhibit 04: Global regenerative medicine market: Segmentation
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Global regenerative medicine market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global regenerative medicine market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global regenerative medicine market - Year over year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global regenerative medicine market by technology - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by technology
  • Exhibit 20: Global regenerative medicine market by cell and tissue-based therapy - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global regenerative medicine market by cell and tissue-based therapy - Year over year growth 2018-2022 (%)
  • Exhibit 22: Approved gene therapy products
  • Exhibit 23: Global regenerative medicine market by gene therapy - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 24: Global regenerative medicine market by gene therapy - Year over year growth 2018-2022 (%)
  • Exhibit 25: Market opportunity by technology
  • Exhibit 26: Global regenerative medicine market: Segmentation by application 2017 (% share)
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global regenerative medicine market by region - Market share 2017-2022 (%)
  • Exhibit 29: Global regenerative medicine market: Regional comparison
  • Exhibit 30: Regenerative medicine market in Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Regenerative medicine market in Americas - Year over year growth 2018-2022 (%)
  • Exhibit 32: Top three countries in Americas
  • Exhibit 33: Regenerative medicine market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: Regenerative medicine market in EMEA - Year over year growth 2018-2022 (%)
  • Exhibit 35: Top three countries in EMEA
  • Exhibit 36: Regenerative medicine market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 37: Regenerative medicine market in APAC - Year over year growth 2018-2022 (%)
  • Exhibit 38: Top three countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: ALLERGAN - Overview
  • Exhibit 46: ALLERGAN - Business segments
  • Exhibit 47: ALLERGAN - Organizational developments
  • Exhibit 48: ALLERGAN - Geographic focus
  • Exhibit 49: ALLERGAN - Segment focus
  • Exhibit 50: ALLERGAN - Key offerings
  • Exhibit 51: ALLERGAN - Key customers
  • Exhibit 52: Integra LifeSciences - Overview
  • Exhibit 53: Integra LifeSciences - Business segments
  • Exhibit 54: Integra LifeSciences - Organizational developments
  • Exhibit 55: Integra LifeSciences - Geographic focus
  • Exhibit 56: Integra LifeSciences - Segment focus
  • Exhibit 57: Integra LifeSciences - Key offerings
  • Exhibit 58: Integra LifeSciences - Key customers
  • Exhibit 59: Medtronic - Overview
  • Exhibit 60: Medtronic - Business segments
  • Exhibit 61: Medtronic - Organizational developments
  • Exhibit 62: Medtronic - Geographic focus
  • Exhibit 63: Medtronic - Segment focus
  • Exhibit 64: Medtronic - Key offerings
  • Exhibit 65: Medtronic - Key customers
  • Exhibit 66: MiMedx Group - Overview
  • Exhibit 67: MiMedx Group - Business segments
  • Exhibit 68: MiMedx Group - Organizational developments
  • Exhibit 69: MiMedx Group - Geographic focus
  • Exhibit 70: MidMedx Group - Segment focus
  • Exhibit 71: MidMedx Group - Key offerings
  • Exhibit 72: MiMedx Group - Key customers
  • Exhibit 73: Organogenesis - Overview
  • Exhibit 74: Organogenesis - Business segments
  • Exhibit 75: Organogenesis - Organizational developments
  • Exhibit 76: Organogenesis - Geographic focus
  • Exhibit 77: Organogenesis - Segment focus
  • Exhibit 78: Organogenesis - Key offerings
  • Exhibit 79: Organogenesis - Key customers
  • Exhibit 80: Zimmer Biomet - Overview
  • Exhibit 81: Zimmer Biomet - Business segments
  • Exhibit 82: Zimmer Biomet - Organizational developments
  • Exhibit 83: Zimmer Biomet - Geographic focus
  • Exhibit 84: Zimmer Biomet - Segment focus
  • Exhibit 85: Zimmer Biomet - Key offerings
  • Exhibit 86: Zimmer Biomet - Key customers
Back to Top